Request Trial
Carpmaels & Ransford
L-R: Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford
18 June 2024FeaturesEuropeAnna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford

Life sciences cases at the UPC will surely rise, but is the court prepared?

Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford explore.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026   A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help.
Europe
Italian medtech startup beats larger US rival in UPC dispute
15 January 2026   Case between AorticLab and Emboline has implications for UPC playbook in terms of requesting security for costs, and conditional counterclaims.
Europe
Bayer secures key Denmark ruling as Xarelto faces expiry pressure
13 January 2026   As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire.


Editor's picks

Final call: Who are the world’s best in-house counsel?
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026

Editor's picks

Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025

More features

Final call: Who are the world’s best in-house counsel?
Italian medtech startup beats larger US rival in UPC dispute
Bayer secures key Denmark ruling as Xarelto faces expiry pressure
Why the US is poised for a patent litigation surge in 2026
How AI will be shaped by legal and regulatory developments in 2026
‘All voices must be heard’: New CIPA president sets out plans for 2026
CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’
Edwards v Meril: Inside the UPC’s landmark medtech showdown